MoneyWorks4Me

NACL Industries informs about statement of deviation or variation

08 May 2026 Evaluate

Pursuant to Regulation 32 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 82(4) of the Securities and Exchange Board of India (Issue of capital and disclosure requirements) regulations, 2018, NACL Industries has confirmed that during the quarter ended March 31, 2026, there was no deviation or variation in the utilisation of the proceeds from the objects stated in the Letter of Offer dated December 08, 2025, pertaining to the Company’s Rights Issue. A statement confirming Nil deviation/variation, along with the Monitoring Agency Report, is enclosed as Annexure A and Annexure B, respectively.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
UPL 550.00
PI Industries 2388.40
Bayer CropScience 3715.95
Sharda Cropchem 750.00
Sumitomo Chem. India 446.15
View more..